Market Overview

Ichiro Kikushige Named CEO of Teva Seiyaku, Japan

Teva Pharmaceutical Industries (NYSE: TEVA) today announced the
appointment of Ichiro Kikushige as Chief Executive Officer (CEO) of Teva
Seiyaku, Japan, effective on May 15, 2013. Mr. Kikushige most recently
was Senior Director of Sales for Eli Lilly Japan K.K. Mr. Kikushige will
replace Makoto Shimada, currently President and CEO of Teva Seiyaku, who
is retiring after having served the pharmaceutical industry in Japan for
nearly 40 years. Mr. Shimada will remain at Teva Seiyaku until June 30,
2013 to facilitate a smooth and orderly transition.

“As an effective leader with more than 30 years of experience in the
pharmaceutical industry, Mr. Kikushige is well-qualified to assume this
important role within Teva in Japan,” said Prof. Itzhak Krinsky,

See full press release

Posted-In: News Guidance Contracts Asset Sales Management Global


Most Popular

Related Articles (TEVA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free